Immunomedics
IMMU
#1179
Rank
ยฃ15.08 B
Marketcap
ยฃ65.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Immunomedics (IMMU)

Revenue in 2020 (TTM): ยฃ17.06 Million

According to Immunomedics's latest financial reports the company's current revenue is ยฃ15.77 Million. In 2017 the company made a revenue of ยฃ2.41 Million an increase over the revenue in the year 2016 that were of ยฃ2.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immunomedics from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ17.06 M
2017ยฃ2.41 M10%
2016ยฃ2.19 M-40.62%
2015ยฃ3.69 M12.78%
2014ยฃ3.28 M-54.93%
2013ยฃ7.27 M158.04%
2012ยฃ2.82 M-91.17%
2011ยฃ31.95 M122.79%
2010ยฃ14.34 M-68.21%
2009ยฃ45.11 M297.36%
2008ยฃ11.35 M329.31%
2007ยฃ2.64 M-65.09%
2006ยฃ7.57 M294.58%
2005ยฃ1.91 M-39.59%
2004ยฃ3.17 M-55.59%
2003ยฃ7.15 M-48.69%
2002ยฃ13.94 M73.31%
2001ยฃ8.04 M